RP-6306 (Synonyms: (S)-RP-6306) |
| Katalog-Nr.GC64369 |
RP-6306 ist ein PKMYT1-Inhibitor, der aus dem Patent WO2021195781A1 Verbindung 182 extrahiert wurde. RP-6306 kann fÜr die Krebsforschung verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2719793-90-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
RP-6306 is a PKMYT1 inhibitor extracted from patent WO2021195781A1 compound 182. RP-6306 can be used for the research of cancer[1].
[1]. Szychowski J, et, al. Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use. WO2021195781A1.
Average Rating: 5 (Based on Reviews and 6 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *